November 1, 2007 - Redsense Medical’s blood loss detection device for monitoring venous needle dislodgement has been granted FDA approval, and is now available for sale in the United States.
The Swedish company says the device has already been granted CE approval. With the FDA’s approval, the maker says Redsense is the first clinically tested, reliable blood loss monitoring system available in the U.S.